RENN FUND INC (RCG)

US7597201059

1.6  +0.02 (+1.27%)

Fundamental Rating

3

Taking everything into account, RCG scores 3 out of 10 in our fundamental rating. RCG was compared to 210 industry peers in the Capital Markets industry. The financial health of RCG is average, but there are quite some concerns on its profitability. While showing a medium growth rate, RCG is valued expensive at the moment.



1

1. Profitability

1.1 Basic Checks

In the past year RCG has reported negative net income.
In multiple years RCG reported negative net income over the last 5 years.
The reported operating cash flow has been mixed in the past 5 years: RCG reported negative operating cash flow in multiple years.

1.2 Ratios

Looking at the Return On Assets, with a value of -6.34%, RCG is doing worse than 94.71% of the companies in the same industry.
RCG has a Return On Equity of -6.39%. This is amonst the worse of the industry: RCG underperforms 83.65% of its industry peers.
RCG's Return On Invested Capital of 0.06% is on the low side compared to the rest of the industry. RCG is outperformed by 81.25% of its industry peers.
Industry RankSector Rank
ROA -6.34%
ROE -6.39%
ROIC 0.06%
ROA(3y)-1.31%
ROA(5y)0.86%
ROE(3y)-1.33%
ROE(5y)1.1%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Looking at the Operating Margin, with a value of 3.50%, RCG is doing worse than 81.25% of the companies in the same industry.
The Gross Margin of RCG (73.94%) is better than 75.00% of its industry peers.
Industry RankSector Rank
OM 3.5%
PM (TTM) N/A
GM 73.94%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

5

2. Health

2.1 Basic Checks

The number of shares outstanding for RCG remains at a similar level compared to 1 year ago.
The number of shares outstanding for RCG has been increased compared to 5 years ago.
There is no outstanding debt for RCG. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

RCG has an Altman-Z score of 55.13. This indicates that RCG is financially healthy and has little risk of bankruptcy at the moment.
RCG has a Altman-Z score of 55.13. This is amongst the best in the industry. RCG outperforms 99.52% of its industry peers.
There is no outstanding debt for RCG. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 55.13
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

A Current Ratio of 0.77 indicates that RCG may have some problems paying its short term obligations.
Looking at the Current ratio, with a value of 0.77, RCG is doing worse than 67.31% of the companies in the same industry.
A Quick Ratio of 0.77 indicates that RCG may have some problems paying its short term obligations.
RCG has a Quick ratio of 0.77. This is in the lower half of the industry: RCG underperforms 66.83% of its industry peers.
Industry RankSector Rank
Current Ratio 0.77
Quick Ratio 0.77

4

3. Growth

3.1 Past

RCG shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 79.10%, which is quite impressive.
The Revenue has grown by 27.92% in the past year. This is a very strong growth!
Measured over the past years, RCG shows a very strong growth in Revenue. The Revenue has been growing by 35.03% on average per year.
EPS 1Y (TTM)79.1%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q-29394.74%
Revenue 1Y (TTM)27.92%
Revenue growth 3Y57.96%
Revenue growth 5Y35.03%
Revenue growth Q2Q26.26%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for RCG. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

2

5. Dividend

5.1 Amount

With a yearly dividend of 0.92%, RCG is not a good candidate for dividend investing.
RCG's Dividend Yield is slightly below the industry average, which is at 7.77.
With a Dividend Yield of 0.92, RCG pays less dividend than the S&P500 average, which is at 2.45.
Industry RankSector Rank
Dividend Yield 0.92%

5.2 History

RCG has been paying a dividend for at least 10 years, so it has a reliable track record.
The dividend of RCG decreased recently.
Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years1

5.3 Sustainability

DP0%
EPS Next 2YN/A
EPS Next 3YN/A

RENN FUND INC

NYSEARCA:RCG (4/25/2024, 2:06:19 PM)

1.6

+0.02 (+1.27%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap11.23M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield 0.92%
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -6.34%
ROE -6.39%
ROCE
ROIC
ROICexc
ROICexgc
OM 3.5%
PM (TTM) N/A
GM 73.94%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.02
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 0.77
Quick Ratio 0.77
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)79.1%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next YN/A
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)27.92%
Revenue growth 3Y57.96%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y